NCT06776393

Brief Summary

The main objective of VOCALISE study is to propose a new approach allowing a better characterization of postoperative dysphonia. This involves associating with dynamic translaryngeal ultrasound optimized acquisitions of the vibration of each vocal fold in phonation simultaneously with voice recordings. A software program to analyze the displacement of arytenoids, markers of substitution of the vocal cords, will be developed to finely quantify the mobility of laryngeal structures, by combining classical methods of motion analysis and deep learning methods. This approach will be evaluated to follow speech therapy rehabilitation in patients with post-operative dysphonia following recurrent nerve injury.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
21mo left

Started Jan 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Jan 2025Jan 2028

First Submitted

Initial submission to the registry

October 23, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Expected
Last Updated

January 15, 2025

Status Verified

October 1, 2024

Enrollment Period

5 months

First QC Date

October 23, 2024

Last Update Submit

January 13, 2025

Conditions

Keywords

motion mode ultrasoundvoice recordingsGRBASI scaleVHI

Outcome Measures

Primary Outcomes (1)

  • To evaluate the contribution of translaryngeal ultrasound combined with acoustic and perceptual measurements of voice and speech classically used in speech therapy for the rehabilitation of patients with dysphonia following surgery.

    Correlation of each quantitative evaluation criterion proposed in ultrasound and voice and speech analysis with the classical voice quality criteria: the VHI (voice handicap index), the GRBASI scale (defined by 5 expert speech pathologists) and a set of acoustic measures of voice and speech.

    6 months

Secondary Outcomes (3)

  • To visualise arytenoid motion in subjects with shadow artifact using the standard dTLUS approach, by optimising dTLUS acquisitions including curvilinear probe acquisitions, gel cushion acquisitions and lateral mode acquisitions.

    6 months

  • To visualise arytenoid motion in subjects with shadow artifact using the standard dTLUS approach, by optimising dTLUS acquisitions including curvilinear probe acquisitions, gel cushion acquisitions and lateral mode acquisitions.

    6 months

  • To visualise arytenoid motion in subjects with shadow artifact using the standard dTLUS approach, by optimising dTLUS acquisitions including curvilinear probe acquisitions, gel cushion acquisitions and lateral mode acquisitions.

    6 months

Study Arms (1)

Patients diagnosed with dysphonia following cervical endocrine surgery

OTHER

Prospective single-center cohort study in patients diagnosed with dysphonia following cervical endocrine surgery

Other: ultrasound

Interventions

"Dynamic translaryngeal Ultrasound Motion mode ultrasound of the laryngeal region during phonation Acoustic recordings VHI questionnaires "

Also known as: voice recordings
Patients diagnosed with dysphonia following cervical endocrine surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient over 18 years of age
  • Obtaining patient's free and informed consent
  • Patients with dysphonia following cervical surgery and referred for speech therapy
  • Social security scheme membership (beneficiary or entitled), excluding MA

You may not qualify if:

  • Known preoperative history of recurrent nerve paralysis (PR)
  • History of laryngeal or vocal cord tumour
  • Surgical complications preventing proper assessment of postoperative vocal cord mobility (tracheotomy, tracheal resection).
  • Patients with a history of thyroid or parathyroid surgery or cervicotomy for another pathology
  • Patient under guardianship or guardianship or deprived of liberty or under safeguard of justice
  • Pregnant or nursing patient
  • Patient does not read or has vision problems
  • Cognitive and/or auditory impairment preventing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

High-Energy Shock Waves

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Christophe TRESALLET, Pr, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christophe TRESALLET, Pr, MD, PhD

CONTACT

Fréderique FROUIN, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: patients who have undergone cervical endocrine surgery.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2024

First Posted

January 15, 2025

Study Start

January 1, 2025

Primary Completion

June 1, 2025

Study Completion (Estimated)

January 1, 2028

Last Updated

January 15, 2025

Record last verified: 2024-10